All stocks ยท MEDICO
MR

MEDICO REMEDIES LIMITED

MEDICO BSE Drug Manufacturers - Specialty & Generic Healthcare

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals;โ€ฆ

ISIN INE630Y01024
Listed โ€”
Quarters tracked 13
Filings 13 docs

About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap331 Cr
P/E23.90
Div Yield0.00 %
Book Valueโ‚น9.10
52w Highโ‚น57.00
52w Lowโ‚น30.20
Face Valueโ‚น2.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 69.40 56.81 58.68 52.64 38.25 41.30 39.49 39.35 30.80 41.32 29.77 42.36 31.47
Expenses 66.10 49.66 54.35 49.91 35.43 34.64 36.38 36.94 27.98 36.67 27.04 39.29 29.01
Operating Profit 3.30 7.15 4.33 2.73 2.82 6.66 3.11 2.41 2.82 4.65 2.73 3.07 2.46
OPM % 4.76 12.59 7.38 5.19 7.37 16.13 7.88 6.12 9.16 11.25 9.17 7.25 7.82
Other Income 1.17 2.87 0.68 1.72 0.66 0.29 1.43 0.68 0.29 0.58 0.27 0.96 0.31
Depreciation 0.72 0.80 0.79 0.73 0.77 0.77 0.76 0.75 0.75 0.74 0.72 0.71 0.71
Interest 0.41 0.90 0.39 0.24 0.28 0.49 0.28 0.21 0.18 0.25 0.22 0.18 0.17
Profit before tax 3.34 8.32 3.83 3.48 2.43 5.69 3.50 2.13 2.18 4.24 2.06 3.14 1.89
Tax % 24.55 29.69 25.07 25.86 25.51 23.90 25.14 27.23 27.06 26.89 30.10 22.61 29.63
Net Profit 2.52 5.86 2.87 2.57 1.82 4.34 2.62 1.55 1.58 3.10 1.45 2.43 1.32
EPS in Rs 0.30 0.71 0.35 0.31 0.22 0.52 0.32 0.19 0.19 0.37 0.17 0.29 0.16

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 206.00151.00145.00140.00121.00122.0089.0098.0061.0054.0067.0051.00
Expenses 189.00136.00132.00131.00114.00117.0086.0095.0058.0050.0063.0048.00
Operating Profit 17.0015.0013.0010.007.005.003.003.003.004.004.003.00
OPM % 8.0010.009.007.006.004.303.202.806.007.005.006.00
Other Income 6.003.002.004.002.001.002.002.001.000.000.000.00
Interest 2.001.001.001.001.001.001.001.002.001.001.001.00
Depreciation 3.003.003.003.002.002.002.002.001.001.001.001.00
Profit before tax 18.0014.0011.0010.006.004.002.002.002.002.002.001.00
Tax % 27.0025.0027.0028.0026.0030.0026.0028.0035.004.0040.0028.00
Net Profit 13.0010.008.007.005.003.002.002.001.002.001.001.00
EPS in Rs 1.581.221.000.870.580.310.200.190.150.250.350.25
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 17.0017.0017.0017.0017.004.004.004.004.003.002.002.00
Reserves 59.0046.0036.0027.0020.0028.0026.0024.0023.0013.0013.0012.00
Borrowings 19.0015.008.0010.0013.0015.0014.0014.0013.0019.0014.008.00
Other Liabilities 59.0043.0036.0034.0028.0028.0032.0035.0020.0013.0017.0014.00
Total Liabilities 153.00120.0096.0087.0077.0076.0075.0076.0059.0048.0046.0036.00
Fixed Assets 20.0021.0021.0022.0018.0015.0013.0012.007.007.007.008.00
CWIP 3.000.000.000.000.000.002.001.004.003.000.000.00
Investments 2.002.002.001.000.001.000.000.000.000.001.001.00
Other Assets 129.0096.0073.0064.0059.0059.0060.0063.0048.0039.0038.0027.00
Total Assets 153.00120.0096.0087.0077.0076.0075.0076.0059.0048.0046.0036.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Cash from Operating Activity 6.005.002.008.006.00-11.001.005.005.00-3.00
Cash from Investing Activity -5.00-3.00-3.00-7.00-2.00-17.00-3.00-4.00-5.00-3.00
Cash from Financing Activity -1.00-1.000.00-2.00-6.0018.003.00-1.00-1.006.00
Net Cash Flow 1.001.00-1.000.00-2.00-10.000.000.000.000.00
Free Cash Flow 1.002.000.002.003.00-28.00-2.001.003.00-4.00
CFO/OP % 64.0058.0043.00111.00104.00-198.0053.00198.00162.00-68.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 145.00138.00125.0094.0092.0082.0098.00109.00102.00122.00107.0053.00
Inventory Days 72.0090.0054.0069.0076.0058.0099.0074.00125.0096.0063.0076.00
Days Payable 119.00117.00105.00108.00113.00100.00143.00149.00147.00112.00106.00122.00
Cash Conversion Cycle 98.00111.0075.0054.0054.0039.0054.0033.0080.00105.0064.006.00
Working Capital Days 87.0090.0074.0054.0052.0050.0061.0049.0088.00110.0053.0021.00
ROCE % 23.0021.0021.0021.0015.0010.008.008.009.0010.0011.0010.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 61.38 61.38 61.38 61.38 62.59 63.79 66.83 73.34 73.34 73.34 73.34 73.34
FIIs 0.08 0.03 0.49 0.30 0.07 0.11 0.39 0.22 0.22 0.29 1.29 1.11
DIIs 0.00 0.00 0.00 0.01 0.01 0.01 0.78 0.97 0.97 0.74 0.00 0.00
Public 38.55 38.60 38.13 38.30 37.33 36.08 32.00 25.47 25.46 25.63 25.36 25.55
No. of Shareholders 15,863 16,189 16,562 18,503 16,474 15,424 14,104 12,887 12,902 10,685 6,052 5,264

Corporate Actions

5 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Other 29 Aug 2024 โ€” โ€” โ€” Annual General Meeting
Other 17 Aug 2023 โ€” โ€” โ€” Annual General Meeting
Split 16 Mar 2023 16 Mar 2023 10:2 โ€”
Other 13 Sep 2022 โ€” โ€” โ€” Annual General Meeting
Bonus 16 Nov 2021 17 Nov 2021 3:1 โ€”

Announcements

5 filings